Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications. Issue 4 (10th February 2020)

• Record Type: Journal Article
• Authors: Kissel, T; Reijm, S; Slot, LM; Cavallari, M; Wortel, CM; Vergroesen, RD; Stoeken-Rijsbergen, G; Kwekkeboom, JC; Kampstra, ASB; Levarht, EWN; Drijfhout, JW; Bang, H; Bonger, KM; Janssen, GMC; van Veelen, PA; Huizinga, TWJ; Scherer, HU; Reth, M; Toes, REM
• Is Part Of: Annals of the rheumatic diseases. Volume 79:Issue 4(2020)
• Page Start: 472
• Page End: 480
• Publication Date: 2020-02-10
• Subjects: rheumatoid arthritis -- autoantibodies -- B cells; Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2019-216499
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Objective: Autoantibodies against antigens carrying distinct post-translational modifications (PTMs), such as citrulline, homocitrulline or acetyllysine, are hallmarks of rheumatoid arthritis (RA). The relation between these anti-modified protein antibody (AMPA)-classes is poorly understood as is the ability of different PTM-antigens to activate B-cell receptors (BCRs) directed against citrullinated proteins (CP). Insights into the nature of PTMs able to activate such B cells are pivotal to understand the 'evolution' of the autoimmune response conceivable underlying the disease. Here, we investigated the cross-reactivity of monoclonal AMPA and the ability of different types of PTM-antigens to activate CP-reactive BCRs. Methods: BCR sequences from B cells isolated using citrullinated or acetylated antigens were used to produce monoclonal antibodies (mAb) followed by a detailed analysis of their cross-reactivity towards PTM-antigens. Ramos B-cell transfectants expressing CP-reactive IgG BCRs were generated and their activation on stimulation with PTM-antigens investigated. Results: Most mAbs were highly cross-reactive towards multiple PTMs, while no reactivity was observed to the unmodified controls. B cells carrying CP-reactive BCRs showed activation on stimulation with various types of PTM-antigens. Conclusions: Our study illustrates that AMPA exhibit a high cross-reactivity towards at least two PTMs indicating that their recognition pattern is not confined to one type of modification. Furthermore, our data show that CP-reactive B cells are not only activated by citrullinated, but also by carbamylated and/or acetylated antigens. These data are vital for the understanding of the breach of B-cell tolerance against PTM-antigens and the possible contribution of these antigens to RA-pathogenesis.